EP2521568
Kallikreinbindiprótín í blóðvökva
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
6.1.2011EP published:
25.7.2018EP application number:
11732145.5
EP translation filed:
17.9.2018Grant published:
15.10.2018EPO information:
European Patent Register
Max expiry date:
5.1.2031Expiry date:
5.1.2027Next due date:
31.1.2027
Title:
PLASMA KALLIKREIN BINDING PROTEINS
Timeline
Today
6.1.2011EP application
25.7.2018EP Publication
17.9.2018Translation submitted
15.10.2018Registration published
5.1.2027Expires
Owner
Name:
Takeda Pharmaceutical Company LimitedAddress:
1-1, Doshomachi 4-chome, Chuo-ku, Osaka-shi, Osaka, JP
Inventor
Name:
SEXTON, Daniel, J.Address:
Melrose, MA, US
Name:
VISWANATHAN, MaliniAddress:
Acton, MA, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
292614 PDate:
6.1.2010Country:
US
Supplementary protection
SPC number:
SPC268
Classification
Categories:
A61K 39/395, C07K 16/18, C07K 16/40
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 18.12.2018
Expires: 5.1.2020
Payer: PATICE, Ólafur Ragnarsson, hrl.
Number: 10
Paid: 18.12.2019
Expires: 5.1.2021
Payer: Ólafur Ragnarsson hrl.
Number: 11
Paid: 17.12.2020
Expires: 5.1.2022
Payer: Patice ehf.
Number: 12
Paid: 15.12.2021
Expires: 5.1.2023
Payer: Patice ehf.
Number: 13
Paid: 22.12.2022
Expires: 5.1.2024
Payer: Árnason Faktor ehf.
Number: 14
Paid: 20.12.2023
Expires: 5.1.2025
Payer: Árnason Faktor ehf.
Number: 15
Paid: 27.12.2024
Expires: 5.1.2026
Payer: Árnason Faktor ehf.
Number: 16
Paid: 7.1.2026
Expires: 5.1.2027
Payer: Árnason Faktor ehf.